You say;
"... illuccix has no patent protection" .. and then you add "... but its not needed ..."!
You know very well that this is a disingenuous statement.
In any case, what do you make of Telix getting mentioned, as one of the two parties (together with Norvartis) that are upset over the compounding pharmacy practices in Australia?
Don't get me wrong: Your loyalty to Telix is enviable. I just think, as a Cu6 shareholder that you say you are, you ought to stay factual about Cu6. I am not asking for favours at all. Truth only!
".....
Australia’s Telix Pharmaceuticals, which makes a diagnostic drug used alongside Novartis’ treatment for prostate cancer, is also on the warpath about copycats being made in local laboratories for a fraction of the price they charge for their proprietary medicines...."
https://www.copyright link/companies/healthcare-and-fitness/big-pharma-takes-on-doctors-over-homebrew-cancer-treatments-20241004-p5kfym
- Forums
- ASX - By Stock
- CU6
- Ann: Head-to-head IIT with SAR-bisPSMA
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
5.44%
!
$2.52

Ann: Head-to-head IIT with SAR-bisPSMA, page-86
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.52 |
Change
0.130(5.44%) |
Mkt cap ! $810.1M |
Open | High | Low | Value | Volume |
$2.39 | $2.54 | $2.37 | $5.141M | 2.072M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6820 | $2.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.52 | 3500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 405 | 2.500 |
1 | 20000 | 2.480 |
4 | 41204 | 2.450 |
1 | 5000 | 2.410 |
5 | 3695 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.520 | 3500 | 1 |
2.540 | 37102 | 3 |
2.550 | 30520 | 6 |
2.580 | 30000 | 2 |
2.590 | 10004 | 2 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online